Filana Therapeutics, Inc.
FLNA· Nasdaq
FLNAFilana Therapeutics, Inc.
Filed Aug 12, 2020 · 10-Q · 43 days after period end · 0001069530-20-000045
| Metric | Q2 2020 | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|---|
| Net Income | -$1.14M | -$1.06M | -$2.45M | -$4.16M |
| EPS Diluted | -$0.05 | -$0.06 | -$0.36 | -$0.64 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR
ended Jun 30, 2020 · filed Aug 12, 2020 · 43 d after period end
